Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
This provides adequate systemic exposure while remaining within commonly researched dose ranges
These pathways are crucial for blood vessel formation, repair, and overall vascular health
This often smooths out side effects, though it doubles injections
Product Name: REGENO Cartalax + TB-500 + BPC-157 Strength: 30mg Total Peptide Content Blend Composition: Cartalax 10mg TB-500 10mg BPC-157 10mg Chemical Name: Multi-Peptide Research Blend (Cartalax + TB-500 + BPC-157) Appearance: White to Off-White Lyophilized Powder Classification: Multi-Peptide Research Compound Purity: Verified by analytical testing prior to release Analytical Methods: HPLC, Mass Spectrometry (MS) Research areas commonly associated with this compound include: Composite Peptide Research Tissue Organization Studies Extracellular Matrix Research Cartilage Signaling Studies Cellular Migration Research Store lyophilized material refrigerated at 28C for routine storage
On WADA's 2026 Prohibited List, BPC-157 falls under S0 (Non-Approved Substances), while TB-500 falls under S2, the peptide hormones and growth factors section
US$ 24.39
US$ 29.63
US$ 26.96
